New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer
A 9.7-month median progression-free survival (mPFS) was reached for the 50mg twice-daily…
MediBeacon Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product for point of care…
MediBeacon Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product for point of care…
MediBeacon Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product for point of care…
MediBeacon Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product for point of care…
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease…
Local Event Raises Awareness of Heart Disease Risks with No-Cost Heart & Kidney Health Screenings in New Orleans
Community Health Initiative Offers No-Cost Screening for Heart and Kidney Risks, Including…
Local Event Raises Awareness of Heart Disease Risks with No-Cost Heart & Kidney Health Screenings in Pearland
Community Health Initiative Offers No-Cost Screening for Heart and Kidney Risks, Including…
Telix Files TLX250-CDx (Zircaix) BLA for Kidney Cancer Imaging
December 29, 2024 16:53 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia…
Continuous Biomarker Monitoring Pioneer Proton Intelligence Inc Announces a $6.95 Million Seed Raise to Initiate Human Trials for Potassium Monitoring in Patients With Kidney Disease
VANCOUVER, British Columbia & MELBOURNE, Australia--(BUSINESS WIRE)--Proton Intelligence Inc., developing the first-ever…